| Characterization of patient-derived intestinal organoids for modelling fibrosis in Inflammatory Bowel Disease I Laudadio, C Carissimi, N Scafa, A Bastianelli, V Fulci, A Renzini, ... Inflammation Research, 1-12, 2024 | | 2024 |
| Whether and when to biopsy coeliac patients: A never-ending story S Cucchiara, B Leter Digestive and Liver Disease 56 (6), 986-987, 2024 | | 2024 |
| Management of collagenous gastritis in children: Case series and literature review S Isoldi, F Viola, S Cucchiara, A Dilillo, D Iorfida, AM Testi, F Fiorentino, ... Indian Journal of Gastroenterology 43 (3), 567-577, 2024 | | 2024 |
| Sa1182 INTERPLAY BETWEEN TRANSCRIPTIONAL AND TRANSLATIONAL PROGRAM DURING INTESTINAL FIBROSIS. N Scafa, C Carissimi, V Fulci, S Cucchiara, N Manfrini, L Stronati, ... Gastroenterology 166 (5), S-376, 2024 | | 2024 |
| Efficacy and safety of a new low-volume PEG with citrate and simethicone bowel preparation for pediatric elective colonoscopy: Phase 3 RCT G Russo, P Alvisi, C Romano, G Angelino, J Lemale, A Lachaux, ... Endoscopy International Open 12 (04), E629-E638, 2024 | | 2024 |
| PARP1 activation induces HMGB1 secretion promoting intestinal inflammation in mice and human intestinal organoids R Vitali, AB Mancuso, F Palone, C Pioli, V Cesi, A Negroni, S Cucchiara, ... International Journal of Molecular Sciences 24 (8), 7096, 2023 | 2 | 2023 |
| Clinical Trials (Clinical Perspective) M Aloi, S Cucchiara Pediatric Inflammatory Bowel Disease, 671-673, 2023 | | 2023 |
| Proteomic analysis identifies three reliable biomarkers of intestinal inflammation in the stools of patients with Inflammatory Bowel Disease R Vitali, F Palone, A Armuzzi, V Fulci, A Negroni, C Carissimi, ... Journal of Crohn's and Colitis 17 (1), 92-102, 2023 | 18 | 2023 |
| ZNF281 promotes colon fibroblast activation in tgfβ1-induced gut fibrosis I Laudadio, A Bastianelli, V Fulci, C Carissimi, E Colantoni, F Palone, ... International Journal of Molecular Sciences 23 (18), 10261, 2022 | 7 | 2022 |
| Colonic inflammation accelerates the progression of liver disease: A protective role of dipotassium glycyrrhizate N Fiaschini, A Negroni, F Palone, R Vitali, E Colantoni, I Laudadio, ... Digestive and Liver Disease 54 (8), 1084-1093, 2022 | 3 | 2022 |
| Evaluation of risk for thromboembolic events in pediatric inflammatory bowel disease A Dilillo, E Del Giudice, S Cucchiara, F Viola, S Maliardo, S Isoldi, ... Journal of Pediatric Gastroenterology and Nutrition 74 (5), 599-604, 2022 | 3 | 2022 |
| A new double immunohistochemistry method to detect mucosal anti-transglutaminase IgA deposits in coeliac children CM Trovato, S Oliva, N Pietropaoli, MG Pignataro, S Berni, A Tancredi, ... Digestive and Liver Disease 54 (2), 200-206, 2022 | 5 | 2022 |
| Crohn’s Disease M Aloi, S Cucchiara Textbook of Pediatric Gastroenterology, Hepatology and Nutrition: A …, 2022 | 2 | 2022 |
| Dietary compliance and quality of life in celiac disease: a long-term follow-up of primary school screening-detected patients D Iorfida, F Valitutti, A Vestri, A Di Rocco, S Cucchiara, R Lubrano, ... Frontiers in Pediatrics 9, 787938, 2021 | 6 | 2021 |
| Transition of inflammatory bowel disease patients from pediatric to adult care: an observational study on a joint-visits approach A Corsello, D Pugliese, F Bracci, D Knafelz, B Papadatou, M Aloi, ... Italian Journal of Pediatrics 47, 1-8, 2021 | 19 | 2021 |
| Infectious Esophagitis S Oliva, S Isoldi, S Cucchiara Textbook of Pediatric Gastroenterology, Hepatology and Nutrition: A …, 2021 | | 2021 |
| Fecal and mucosal microbiota profiling in pediatric inflammatory bowel diseases L Putignani, S Oliva, S Isoldi, F Del Chierico, C Carissimi, I Laudadio, ... European Journal of Gastroenterology & Hepatology 33 (11), 1376-1386, 2021 | 16 | 2021 |
| Assessment of a new score for capsule endoscopy in pediatric Crohnʼs disease (CE-CD) S Oliva, S Veraldi, S Cucchiara, G Russo, A Spagnoli, SA Cohen Endoscopy International Open 9 (10), E1480-E1490, 2021 | 11 | 2021 |
| Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study MM Leonard, F Valitutti, H Karathia, M Pujolassos, V Kenyon, B Fanelli, ... Proceedings of the national academy of sciences 118 (29), e2020322118, 2021 | 110 | 2021 |
| Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND … PA Flume, RF Biner, DG Downey, C Brown, M Jain, R Fischer, ... The Lancet Respiratory Medicine 9 (7), 733-746, 2021 | 40 | 2021 |
